Axcan sets meeting date for merger vote

By Lisa Kerner

Charlotte, N.C., Dec. 26 - Axcan Pharma Inc. shareholders will vote on the company's acquisition by TPG Capital at a special meeting on Jan. 25 at 9:30 a.m. ET in Montreal.

Shareholders will be asked to approve a plan of arrangement under the Canada Business Corporations Act involving Axcan, its shareholders and TPG affiliate 4445660 Canada Inc.

On Nov. 29, Axcan agreed to be acquired by TPG and its affiliates in an all-cash transaction valued at some $1.3 billion, or $23.35 per common share.

Axcan is a Mont-Saint-Hilaire, Quebec, specialty pharmaceutical company.

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.